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Abstract
Background: Nitric oxide is key to endothelial regeneration, but it is still unknown whether endothelial cell (EC)
loss results in an increase in NO levels at the wound edge. We have already shown that endothelial damage
induces a long-lasting Ca2+ entry into surviving cells though connexin hemichannels (CxHcs) uncoupled from their
counterparts on ruptured cells. The physiological outcome of injury-induced Ca2+ inflow is, however, unknown.
Methods: In this study, we sought to determine whether and how endothelial scraping induces NO production
(NOP) in the endothelium of excised rat aorta by exploiting the NO-sensitive fluorochrome, DAF-FM diacetate and
the Ca2+-sensitive fluorescent dye, Fura-2/AM.
Results: We demonstrated that injury-induced NOP at the lesion site is prevented in presence of the endothelial
NO synthase inhibitor, L-NAME, and in absence of extracellular Ca2+. Unlike ATP-dependent NO liberation, the NO
response to injury is insensitive to BTP-2, which selectively blocks store-operated Ca2+ inflow. However, injury-
induced NOP is significantly reduced by classic gap junction blockers, and by connexin mimetic peptides
specifically targeting Cx37Hcs, Cx40HCs, and Cx43Hcs. Moreover, disruption of caveolar integrity prevents injury-
elicited NO signaling, but not the accompanying Ca2+ response.
Conclusions: The data presented provide the first evidence that endothelial scraping stimulates NO synthesis at
the wound edge, which might both exert an immediate anti-thrombotic and anti-inflammatory action and
promote the subsequent re-endothelialization.
Background
Endothelial injury is regarded as the early event that
leads to the onset and progression of severe vascular
disorders, such as thrombosis, hypertension, and athero-
sclerosis [1]. Endothelial cell (EC) loss physiologically
occurs due to physiological turnover in focal areas of
the inner surface of blood vessels which are adjacent to
regions with low or absent replication [2,3]. When the
extent of EC loss is such small, i.e. limited to a belt of
cells around the whole circumference of the arterial ves-
sel, the re-endothelization process is driven by prolifera-
tion, spreading, and migration of surviving ECs into the
damaged site [4]. On the other hand, larger areas of injury
may release chemical messages, such as concentration gra-
dients of vascular endothelial growth factor (VEGF) and
stromal derived factor-1a (SDF-1a), that recruit circulat-
ing endothelial progenitor cells to the wound edge in
order to replace damaged endothelium [5-10]. The break
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in the anatomic integrity of vascular endothelium is signif-
icantly larger in subjects undergoing medical interven-
tions, such as deployment of endovascular devices and
percutaneous transluminal coronary angioplasty [2,11,12].
Such a heavy loss of ECs from the vascular wall dampens
the beneficial effects of reconstructive surgery and
prompts the quest for pharmacological treatments aiming
at restoring the continuity of endothelial monolayer
[2,11-13]. Accordingly, the de-endothelialisation of arterial
vessels may cause thrombi formation and neointimal
hyperplasia, giving raise to a process termed as “in-stent
restenosis” (ISR) which renarrows the arterial lumen
[2,11,12]. Drug-eluting stents (DES) may be implanted
during or after angioplasty to inhibit neointimal hyperpla-
sia and prevent ISR [2,12,14]. Unfortunately, the most
commonly employed stents deliver drugs, such as siroli-
mus and paclixatel, that cause a long-term inhibition of
endothelial proliferation and migration. These untoward
off-target effects significantly delay endothelial regrowth,
thereby leaving uncovered the surface of the stent and
increasing the risk of late in-stent thrombosis [14,15].
Aging is accompanied by a decline in the healthy func-
tion of multiple organ systems, leading to increased inci-
dence of mortality from many diseases. Oxidative stress
and elevated ROS (Reactive oxygen species) has been
implicated in the mechanism of senescence and aging;
they are also involved in cancer, diabetes, neurodegenera-
tive, cardiovascular and other diseases [16,17] Overpro-
duction of oxidant molecules is due to several stress
agents such chemicals, drugs, pollutants, high-caloric
diets and exercise [18].
Nitric oxide (NO), a gasotransmitter that may be
synthesized and released by ECs [1,19], might play a key
role in healing injured endothelium. Accordingly, NO
inhibits apoptosis and enhances EC proliferation, migra-
tion, and tubulogenesis [19]. Moreover, NO might serve
as anti-inflammatory signal at the injured site by pre-
venting local platelet activation and thrombus formation,
by causing vasorelaxation, and by inhibiting the pheno-
typic switch of vascular smooth muscle cell (VSMC)
[1,19]. Restoration of NO production at the site of vas-
cular injury may attenuate neointimal hyperplasia and
adverse the onset of the atherosclerotic process [20]. In
vascular endothelium, NO may be synthesized by two dif-
ferent isoforms of NO synthase (NOS), namely inducible
NOS (iNOS/NOS2), which mediates NO liberation during
inflammatory reactions, and endothelial NOS (eNOS/
NOS3), which is preferentially recruited by stimuli [19,21].
The catalytic reaction consists in the conversion of L-argi-
nine to L-citrulline and requires several cofactors, such as
NAPDH, tetrahydrobiopterin and O2 [19]. Unlike iNOS,
which is inducible and Ca2+-independent, both iNOS and
eNOS are constitutive and bear a calmodulin-binding site
whose binding to cytosolic Ca2+ is essential to stimulate
NO synthesis [19]. In several types of ECs, eNOS is prefer-
entially recruited by Ca2+ store-operated Ca2+ entry
(SOCE), which is gated by depletion of the inositol-1,4,5-
trisphosphate (InsP3)-sensitive stores within the endoplas-
mic reticulum (ER) [8,22]. This feature is due to the close
proximity between eNOS and SOC channels at the caveo-
lae, cholesterol-enriched surface microdomains that
compartmentalize signal transduction molecules [23].
Cholesterol-binding drugs, such as methyl-b-cyclodextrin
(MbCD), have been used to disrupt caveolae and impair
NO signalling in vascular endothelium [24]. That NO is
involved in EC response to injury has been suggested by
the elevation in both eNOS protein and enzyme activity in
the regenerating endothelium of rat aorta [25]. Moreover,
a recent study carried out on this preparation reported an
increase in [Ca2+]i in ECs nearby the lesion site [2,9,26,27].
The Ca2+ response to injury comprises an initial peak,
mainly due to Ca2+ release from InsP3-sensitive receptors
(InsP3Rs), which is followed by a long-lasting decay phase
mediated by Ca2+ entry across the plasma membrane [27].
InsP3 synthesis requires phospholipase C (PLC) activation
by ATP (or ATP-derived nucleotides) released from rup-
tured cells [27]. Ca2+ inflow is supported by connexin (Cx)
hemichannels (CxHcs), which have recently been
described as alternative Ca2+ entry routes in vascular ECs
as well as other non-excitable cell types [26-31]. Cxs may
be classified on the basis of the molecular weight with
three main isoforms (Cx37, Cx40, and Cx43) being found
in ECs from several vascular beds, including rat aorta
[32,33]. Despite the available evidences show an increase
both in eNOS activity and in [Ca2+]i within lesioned
endothelium, there is no report of injury-induce NO
release in blood vessels. Understanding the signal trans-
duction machinery leading to endothelial activation and
NO synthesis might be clinically relevant to design alter-
native strategies to restore endothelial integrity and
prevent ISR.
In the present investigation, we sought to determine
whether NO synthesis occurs in ECs facing the injury
site of excised rat aorta. We further aimed at elucidating
the signal transduction pathway responsible for NO
release by lesioned endothelium. These goals were
accomplished by loading ECs with Fura-2/AM, a Ca2+-
sensitive fluorochrome, and DAF-FM diacetate, a NO-
sensitive fluorescent dye. We provided, for the first
time, the evidence that mechanical injury induces a long
lasting NO production (NOP) in cells nearby the lesion
site which requires Ca2+ entry through uncoupled
Cx37Hcs, Cx40Hcs, and Cx43Hc. These results might
aid in developing novel pharmacological treatments
devoted to restore endothelial integrity upon invasive
medical interventions.
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Methods
Dissection of the aorta
Wistar rats aged 2-3 months were sacrificed with an
overdose of diethyl ether. The thoracic and abdominal
aorta were dissected out and perfused with physiological
salt solution (PSS). The vessel was cleaned of the sur-
rounding connective tissue, cut in ~5 mm long rings,
stored in PSS at room temperature (22-24 °C) and used
within 5 hours. All the animal protocols were approved
by the East Tennessee State University’s Animal Care
and Use Committee. All experiments conform to the
Guide for the Care and Use of Laboratory Animals pub-
lished by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996). The animal hand-
ling was under the continuous control of the Veterinary
Surgeon of the University of Pavia.
Solutions
PSS had the following composition (in mM): 150 NaCl,
6 KCl, 1.5 CaCl2, 1 MgCl2, 10 Glucose, 10 Hepes. In
Ca2+-free solution (0 Ca2+), Ca2+ was substituted with
2 mM NaCl, and 0.5 mM EGTA was added. Solutions
were titrated to pH 7.4 with NaOH. Aortic rings were
bathed in 0 Ca2+ for no longer than 90 sec before indu-
cing the injury. Control experiments have demonstrated
that such a short pre-incubation period is not able
deplete intracellular Ca2+ stores [27].
[Ca2+]i and NO measurements.
The technique used to evaluate changes in [Ca2+]i in
intact endothelium has been previously described
[26,27,34-37]. The aortic ring was opened and loaded
with 16 µmol Fura-2/AM for 60 min at room tempera-
ture, washed and fixed by small pins with the luminal
face up. In situ ECs were visualized by an upright epi-
fluorescence Axiolab microscope (Carl Zeiss, Oberko-
chen, Germany), equipped with a Zeiss ×63 Achroplan
objective (water-immersion, 2.0 mm working distance,
0.9 numerical aperture). ECs were excited alternately at
340 and 380 nm, and the emitted light was detected at
510 nm. The exciting filters were mounted on a filter
wheel (Lambda 10, Sutter Instrument, Novato, CA,
USA). Custom software, working in the LINUX environ-
ment, was used to drive the camera (Extended-ISIS
Camera, Photonic Science, Millham, UK) and the filter
wheel, and to measure and plot on-line the fluorescence
from 10-15 rectangular “regions of interest” (ROI)
enclosing one single cell. [Ca2+]i was monitored by mea-
suring, for each ROI, the ratio of the mean fluorescence
emitted at 510 nm when exciting alternatively at 340
and 380 nm (shortly termed “ratio”). An increase in
[Ca2+]i causes an increase in the ratio. Ratio measure-
ments were performed and plotted on-line every 5 s.
The experiments were performed at room temperature
(21-23 °C).
NO production in ECs in intact rat aorta was moni-
tored with the membrane permeant 4-Amino-5-methy-
lamino-2’,7’-difluorofluorescein (DAF-FM) diacetate.
Once open, the aortic ring was fixed by small pins with
the luminal side facing up, loaded with 10 µM DAF-FM
for 60 min at room temperature and washed in PSS for
one hour. DAF-FM fluorescence was measured by using
the same equipment described for Ca2+ recordings but
with a different filter set, i.e. excitation at 480 nm and
emission at 535 nm wavelength (emission intensity was
shortly termed “NOi”). NO measurements were per-
formed and plotted on-line every 5 s. Again, off-line ana-
lysis was performed by using custom-made macros
developed by Microsoft Office Excel software. The
experiments were performed at room temperature. DAF-
FM is essentially non-fluorescent until it irreversibly
reacts with the nitrosonium cation produced by sponta-
neous oxidation of newly synthesized NO. The resulting
fluorescent compound is trapped in the cytoplasm, so
that DAF-FM fluorescence summates with continual NO
production. As also found in bovine aortic ECs [38],
DAF-FM fluorescence in rat aortic ECs underwent a per-
sistent and linear increase likely due to the basal NO
synthesis [19]. Accordingly, the change in baseline fluor-
escence was dramatically reduced when aortic rings were
pre-incubated with L-NAME (5 mM), which inhibits
eNOS by competing with its natural substrate, L-arginine
(data not shown), or in 0Ca (data not shown). This obser-
vation was somehow expected since aortic endothelium
has long been known to regulate vascular tone by basal
release of NO [19]. Therefore, for each experiment, the
basal DAF-FM signal was recorded for at least 20 min-
utes and the resulting curve fitted off-line by a linear
regression equation in order to calculate the slope (i.e.
the rate) of basal fluorescence increase. The slope was
subtracted from the recorded trace, thus enabling to
measure S-Nitroso-N-acetylpenicillamine (SNAP)-, ATP-
and injury-induced NOP independently on basal eNOS
activity [39] (see below). NO synthesis was evaluated by
subtracting the baseline level (1 min before the increase
in DAF-FM fluorescence) to the average value of the pla-
teau phase (1 min before the end of the recording)
recorded upon either ATP administration or endothelial
scraping.
In order to assess the ability of the fluorimetric set up
to detect evoked changes in intracellular NO levels, aor-
tic rings were exposed to the NO donor, SNAP, and
ATP, which has been shown to elicit NO production in
a variety of ECs from different vascular districts [38,40].
As shown in Figure 1A and Figure 1B, respectively,
SNAP (500 µM) and ATP (300 µM) caused an increase
in the intensity of DAF-FM fluorescence in 19 out of
19 cells and in 170 out of 170 cells, respectively.
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On average, L-NAME (5 mM) reduced by 86% ATP-
induced NO production (0.025 ± 0.001, n = 170, vs.
0.0041 ± 0.0009, n = 192, p < 0.001) (Figure 1B).
Mechanical disruption of ECs
As shown in [26,27], aortic endothelium was injured
under microscopic control by means of a glass microelec-
trode with a broken tip of about 30 µm diameter, driven
by an XYZ hydraulic micromanipulator (Narishige,
Japan). Images of either Fura-2 or DAF-FM/Fura-2
loaded ECs, together with numbered ROIs, were taken
before the lesion, in order to identify the cells facing the
injury site. As aforementioned, the dissection procedure
could itself damage the intimal layer and cause SMCs to
be loaded with Fura-2. These rings were, therefore, dis-
carded. The microelectrode was first positioned almost
parallel and very near to the endothelium surface. It was
then moved downward, along the Z-axis, until the elec-
trode tip gently touched the endothelium, and moved
horizontally across the visual field to scrape 1-3 consecu-
tive rows of ECs along the whole diameter of the aortic
ring. The following lesion was 170 μm long and 20 μm
wide. This procedure, which allowed monitoring of NO
signals in ECs adjacent to the lesion, mimics the ablation
of the endothelial lining achieved in pre-clinical studies
addressing the cellular mechanisms of intimal regrowth
upon stent deployment [41-43]. The scraping of the
endothelial monolayer imposed a physical stretching on
the underlying SMCs which resembles the condition
occurring during clinical interventions. Ethidium bro-
mide (EB), a fluorescent molecule unable to cross an
intact plasma membrane and therefore indicative of
damaged/dead cells, was used to check the viability of
both ECs nearby the injury and underlying SMCs [27].
When smooth muscle fibers were lesioned by mechanical
scratching and stained by EB, the experiments were
discarded.
Figure 1 NO production in rat aortic endothelium. A, exposition to SNAP (500 μM) caused an increase in DAF-FM fluorescence in native rat
aortic endothelium in situ. The trace is the mean±SE of 11 cells from the same visual field. B, ATP (300 μM) induced an elevation in intracellular
NO (closed circles) that was dramatically hampered when the rings were pre-treated with L-NAME (5 mM) for 40 min (white circles). The traces
are the mean±SE, respectively, of 10 (PSS) and 8 (L-NAME) cells from two aortic rings harvested from the same animal on the same day.
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Data analysis
For each protocol, data were collected from at least
three rats. The amplitude of the peak Ca2+ response was
measured as the difference between the ratio at the peak
and the mean ratio of 1 min baseline before the peak.
The details of NO measurements have been reported
above. Only cells residing in the first row nearby the
wound were used to elaborate the average value. For
Ca2+ and NO measurements, statistical comparisons
were made by Student’s t-test for unpaired observations.
Chemicals
Fura-2/AM and DAF-FM was obtained from Molecular
Probes (Molecular Probes Europe BV, Leiden, The
Netherlands). N-(4-[3,5-bis(trifluoromethyl)-1H-pyrazol-
1-yl]phenyl)-4-methyl-1,2,3-thiadiazole-5-carboxamide
(BTP-2) was purchased from Calbiochem (La Jolla, CA,
USA). All other chemicals were purchased from Sigma.
Cx-mimetic peptides, including 37,43Gap27 and 40Gap27,
were synthesized by Severn Biotech (Kidderminster,
UK); purity was >95%. In more detail, 37,43Gap27 and
40Gap27 mimic a highly conserved SRPTEK sequence
present in the second extracellular loop of Cxs 37 and
43 and of Cx 40, respectively [15,19]. Their scrambled
versions were also synthesized by Severn Biotech. All
other chemicals were of analytical grade and obtained
from Sigma.
Results
Injury augments intracellular NO levels in the intact
endothelium of rat aorta
Figure 2A depicts the injury-induced increase in [Ca2+]i
occurring within the ECs adjacent to the lesion site and
which have lost their contact with the scraped cells. The
Ca2+ signal consisted in an initial transient peak, mainly
due to InsP3-dependent Ca
2+ release, followed by a pro-
longed decay phase caused by Ca2+ entry from the
extracellular milieu [27]. When the damage was per-
formed on an aortic ring loaded with DAF-FM, it
induced a gradual increase in fluorescence that reached
a plateau after about 20 min (Figure 2B). This feature is
consistent with the concomitant long-lasting Ca2+ inflow
[27], which might sustain NO synthesis [19,38]. In the
presence of the eNOS inhibitor, L-NAME (5 mM),
mechanical damage failed to augment intracellular NO
(Figure 2B). The statistical analysis is reported in Figure
3A. Similar to the intercellular Ca2+ wave, which did not
spread farther than the 4th raw of cells, the amplitude of
the NO signal significantly (p < 0.05) decayed at this
location (Figure 2C). This feature hints at a strong cor-
relation between the increase in [Ca2+]i triggered by the
injury and the accompanying NO synthesis.
Injury-induced NOP depends on extracellular Ca2+ entry
It has long been known that, in vascular endothelium,
eNOS is selectively activated by Ca2+ inflow rather than
intracellular Ca2+ release [8,22,40]. When mechanical
damage was carried out in absence of extracellular Ca2+,
a maneuver which abolished the prolonged decay-phase
of the Ca2+ signal, the injury did not result in a detect-
able NOP (Figure 3A). The involvement of intracellular
Ca2+ mobilization was investigated with the aid of thap-
sigargin (2 μM), an inhibitor of the endoplasmic reticu-
lum Ca2+-ATPase, which prevents Ca2+ re-uptake into
the stores and leads to their depletion. Preliminary
experiments showed that pre-incubating the rings for 30
min with 2 μM thapsigargin abolished the intracellular
Ca2+ mobilization triggered by supramaximal concentra-
tions of ATP (300 μM) (n = 79; data not shown). There-
fore, such a treatment causes the depletion of the Ca2+
reservoir underlying the initial Ca2+ response to injury
[27]. The NO signal induced by endothelial scraping,
however, was not significantly affected by thapsigargin
(Figure 3A). Overall, these results strongly suggest that
injury-promoted NOP in surviving ECs is sustained by
Ca2+ entry, while is insensitive to Ca2+ release from ER.
SOCE represents the preferential route for extracellular
Ca2+ to engage eNOS in ECs [8,22,40]. However, BTP-2
(20 μM), a widely employed blocker of store-dependent
Ca2+ inflow [6,8], does not significantly affect injury-
induced NO synthesis (Figure 3A). We subsequently
focused on the response to ATP, which elicits a BTP-
2-sensitive SOCE in rat aortic endothelium [27]. ATP-
induced NO synthesis was strongly inhibited in 0 Ca2+
(Figure 3B) and in the presence BTP-2 (Figure 3B).
Collectively, these data concur with our previous find-
ings on injury-induced Ca2+ inflow and rule out a
detectable role for SOCE in NO release by lesioned
endothelium.
Gap junction inhibitors reduce NO synthesis induced by Ca2+
entry in injured endothelium
The long-lasting decay phase of injury-induced Ca2+ ele-
vation in rat aortic rings is dramatically diminished by
gap junction blockers, such as octanol, palmitoleic acid
and oleamide [26,27,44,45]. In agreement with the Ca2+
measurements [27], octanol (4 mM), oleamide (200 μM),
and palmitoleic acid (50 μM) dramatically affected NO
synthesis elicited by endothelial scraping (Figure 3C). In
the light of our previous observations [27], these findings
hint at a role for Ca2+ inflow through CxHcs in mediating
NOP in injured endothelium. We assessed the specificity
of gap junction blockers by measuring the Ca2+ response
to ATP (20 μM) in the presence of octanol. At this dose,
ATP evokes an InsP3-dependent Ca
2+ release, which is
subsequently buffered by the combined action of SERCA
and Na+/Ca2+ exchanger [27,34,46]. As shown in Figure
4, pre-incubating rat aortic rings with 4 mM octanol for
20 min did not significantly affect either the magnitude
of the [Ca2+]i elevation or the rate of its decay phase to
the baseline. This result concurs with previous evidence
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about the efficacy of gap junction blockers as selective
uncoupling drugs in rat aortic rings [47,48], and further
support the role of CxHcs in mediating NO synthesis in
injured endothelium.
Effect of Cx-mimetic peptides on injury-induced Ca2+
elevation and NO production
Rat aortic endothelium may express three Cx isoforms,
namely Cx37, Cx40, and Cx43 [32,49], albeit a recent
Figure 2 NO synthesis induced by mechanical injury rat aortic endothelium. A, Ca2+ signal elicited by lesioning rat aorta in PSS. The trace,
recorded from a single cell, is representative of 10 cells from the same visual field. B, injury induced an elevation in intracellular NO levels that
was abolished when the cells were pre-treated with the eNOS inhibitor, L-NAME (5 mM), for 40 min. The traces are the mean±SE, respectively, of
10 (PSS, closed circles) and 5 (L-NAME, open circles) cells from two aortic rings harvested from the same animal on the same day. C, mean±SE
of the NO signal recorded at increasing distance from the lesion site. In this and the following figures, the arrow indicates when injury is
performed. Asterisk indicates a level of significant difference <0.05.
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work reported the presence of Cx32 in various cultured
human ECs [50]. The contribution of each Cx isotype to
injury-evoked NO liberation was examined by exploiting
Cx-mimetic peptides containing amino acid sequences
corresponding to the Gap27 extracellular domain of
Cx37 and Cx43 (37,43Gap27) and to the Gap27 extracellu-
lar domain of Cx40 (40Gap27). Although initially
designed to impair gap junctional communication, the
primary target of these compounds is provided by
CxHcs. The extracellular-loop sequence that interacts
with the peptides is freely available in the CxHc form
[51], so that full blockade of the unpaired hemichannel
requires a much shorter pre-incubation (minutes vs.
hours or longer) and much lower doses (micromolar vs.
millimolar range) than inhibition of gap junctional cou-
pling [51]. These compounds have been found to selec-
tively inhibit Cx-dependent signalling in a variety of cell
types, including rat aortic ECs [49,52], when the genetic
Figure 3 Amplitude of the NO response to injury (A and C) and ATP (B) following the designated treatments. The asterisk indicates a
level of significant difference <0.05. The number of ECs analyzed in each condition, harvested from 3-9 animals, is indicated above the bars. See
the text for drug concentrations.
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suppression of specific Cx isoforms is not feasible, such
as in rat endothelium [33,45]. In addition, Cx-mimetic
peptides do not present the drawbacks reported in Cx-
deficient mice [53]. For instance, Cx40-/- mice manifest
either higher [54] or lower [55] levels of Cx37 as well as a
significant decrease in Cx43 expression [56]. This feature
makes the interpretation of the physiological data col-
lected from these animals difficult. Incubating the aortic
rings for 1 hour with either 37,43Gap27 (300 μM) or
40Gap27 (300 μM) significantly (p < 0.05) reduced injury-
Figure 4 Ethanol does not significantly affect the Ca2+ response to ATP. A, 20 min pre-incubation with octanol (4 mM) does not
remarkably affect either the amplitude or the kinetics of the Ca2+ response to ATP (20 μM). The trace is the average of 16 cells from the same
microscopic field of view. B, mean±SE of the peak of ATP-induced elevation in [Ca2+]i. The asterisk indicates a level of significant difference
<0.05. The number of ECs analyzed in each condition is indicated above the bars. C, B, mean±SE of the rate of decay of ATP-induced Ca2+
signal. The decay was measured by fitting the Ca2+ tracings with a first order exponential equation (OriginPro 7, OriginLab Corp, Northampton
MA). The asterisk indicates a level of significant difference <0.05. The number of ECs analyzed in each condition is indicated above the bars.
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evoked NOP (Figure 5A and Figure 5B). The statistical
analysis of these experiments has been reported in
Figure 5C and Figure 5D. NO signalling was unaffected
by peptides corresponding to scrambled sequences in
Gap27, indicating that the inhibition resulted from speci-
fic sequence recognition on the selected Cx isotypes
(Figure 5C and Figure 5D). Therefore, it is reasonable to
conclude that Ca2+ entry driving eNOS activity and NO
liberation at the wound edge is supported by Cx37Hcs,
Cx40Hcs, and Cx43Hcs. As discussed elsewhere [57],
eNOS activation requires a sub-plasmalemmal Ca2+
increase rather a bulk increase in cytosolic Ca2+ levels.
Such a localized Ca2+ event may not even be detected by
conventional epifluorescence microscopy [58]. As a con-
sequence, we went on in assessing whether Cx-mimetic
peptides targeting Cx37, Cx40, and Cx43 were also able
to reduce the long-lasting decay phase of the Ca2+
response to mechanical damage. Figures 6A to 6D depict
that neither 37,43Gap27 (300 μM) nor 40Gap27 (300 μM)
significantly reduce either the initial Ca2+ peak or the
subsequent decay phase. Rather, both Cx-mimetic pep-
tides increased the amplitude of the initial Ca2+ response
(Figure 6A-6C). Consistently, acute application of both
peptides during recovery of the Ca2+ signal towards the
baseline did not decreased the [Ca2+]i (n = 31,
40Gap27;
n = 52, 37,43Gap27) (not shown). The same results were
found by extending the pre-incubation period with both
37,43Gap27 and 40Gap27 up to 2 hours (Figure 6B-6D)
[49]. Taken as a whole, these results suggest that
Cx37Hcs, Cx40Hcs, and Cx43Hcs mediate the sub-
membranal Ca2+ elevation responsible for eNOS activa-
tion, but not the bulk increase in [Ca2+]i caused by
mechanical damage in surviving ECs. As the pharmacolo-
gical profile of the decay phase is consistent with a CxHc
Figure 5 Connexin-mimetic peptides affect injury-induced NO synthesis. 1 hour pre-incubation with either 37,43Gap27 (300 μM) (A) or
40Gap27 (300 μM) (B) dramatically attenuated the increase in intracellular NO levels provoked by endothelial lesion. For sake of clarity, the
control curve has been depicted in each Panel. All the experiments depicted in this figure have been carried out on the same day on different
rings isolated from the same animal. The control (PSS, closed circles) trace is the mean±SE of 9 cells, while the 37,43Gap27 (open circles in Panel
A) and 40Gap27 traces (open circles in Panel B) are, respectively, the mean±SE of 5 and 7 cells. C and D, mean±SE of NOP elicited by injury
following the designated treatments. Each drug was applied was 20 min before carrying out the lesion. The asterisk indicates a level of
significant difference <0.05. The number of ECs analyzed in each condition is indicated above the bars. See the text for drug concentrations
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pathway [2,26,27], it is conceivable that one or more
additional Cx isoforms are expressed in rat aortic
endothelium.
NO synthesis is abolished by caveolar disruption with
MbCD
NO production by a highly localized Ca2+ signal sneak-
ing beneath the plasma membrane requires the spatial
proximity between the Ca2+ source and eNOS [57,58].
Caveolae represent a signalling platform responsible for
translating Ca2+ entry into specific signal transduction
pathways [24,57]. MbCD is a cholesterol-binding agent
which has been widely employed to disrupt caveolar
integrity in a variety of cell types, including ECs [24].
We first probed MbCD (10 mM) efficacy in impairing
caveolae-dependent signalling by testing its effect on
SOCE. As shown elsewhere [27,35], SOCE sustains the
Ca2+ response to high concentrations of ATP (300 μM)
in the endothelium of excised rat aorta. As shown in
Figure 7A, MbCD significantly reduced the amplitudes
of both the initial Ca2+ peak and the subsequent plateau,
which are both supported by SOCE [27]. Consistently,
MbCD inhibited ATP-dependent NOP in 85 out of 85
cells, whereas 93 out of 93 untreated cells liberated NO
when exposed to ATP (Figure 7B). Then, to assess the
role of caveolae in coupling CxHcs-mediated Ca2+ inflow
with eNOS activation, rat aortic rings were pre-incubated
(30 min) in the presence of MbCD (10 mM). Exposition
to MbCD did not significantly affect the Ca2+ response to
injury (Figure 8A and Figure 8B), but prevented the
downstream NO synthesis (Figure 8C and Figure 8D).
Collectively, these data indicate that the proximity
between CxHcs and eNOS is maintained by the caveolar
Figure 6 Connexin mimetic peptides do not impair injury-induced elevation in [Ca2+]i in rat aortic endothelium. A, 1 hour pre-
incubation with either 37,43Gap27 (300 μM) (gray trace) or 40Gap27 (300 μM) (dark grey trace) did not reduce injury-elicited intracellular Ca2+
signals in native endothelium of rat aorta. B, 2 hour pre-incubation with both 37,43Gap27 (300 μM) and 40Gap27 (300 μM) (grey trace) did not
impair the intracellular Ca2+ response to injury at wound edge of rat aortic endothelium. C and D, mean±SE of NOP elicited by injury following
the designated treatments. The asterisk indicates a level of significant difference <0.05. The number of ECs analyzed in each condition is
indicated above the bars.
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signalling platform within the plasma membrane. This
feature is consistent with the highly localized nature of
the Ca2+ signal driving NO synthesis.
Discussion
Endothelial-derived NO drives a number of processes
which protects the vessel wall by pro-atherosclerotic
events and maintain vascular homeostasis. NO exerts
both an anti-aggregating and anti-inflammatory action,
promotes endothelial survival, proliferation and migra-
tion, and prevents the phenotypic remodeling of the
underlying layer of SMCs [2,19,59]. The present investi-
gation provides the first evidence that endothelial abla-
tion similar to that induced in vivo by stent deployment
causes a local increase in NO levels by activating the
ECs immediately adjacent to the lesion site. We further
elucidated the molecular machinery responsible for
eNOS recruitment and showed that injury-induced NOP
is triggered by Ca2+ entry though Cx37Hcs, Cx40Hcs,
and Cx43Hcs. The coupling between Ca2+ inflow and
eNOS activation might be provided by cholesterol
enriched membrane microdomains, such as caveolae.
These data shed novel light on the endothelial reaction
to mechanical scraping and hint at the Ca2+ machinery
as a novel target to restore endothelial integrity after
reconstructive surgery and to treat vascular diseases
[2,12].
NO synthesis in the injured endothelium of rat aorta is
supported by CxHcs-mediated Ca2+ entry
The procedure that we adopted for mechanical scraping
mimics the partial denudation of the endothelial mono-
layer that has been described upon stent deployment in a
number of pre-clinical models [41-43]. The extent of the
lesion we inferred is smaller as compared to the degree
Figure 7 Caveolar impairment impairs both the Ca2+ response to ATP and the accompanying NO production in rat aortic
endothelium. A, pre-treatment with 10 mM MbCD to disrupt caveolae significantly hinders both the magnitude and the plateau of the Ca2+
response to ATP (300 μM). Both phases depend on store-dependent Ca2+ inflow when ATP is administered at this dose. The traces are the mean
±SE of 220 (PSS, black trace) and 186 cells (MbCD, red trace), respectively, from no less than three different animals. B, MbCD (10 mM)
suppresses ATP-induced NO synthesis. The traces are the mean±SE, respectively, of 150 (PSS, closed circles) and 4 (MbCD, open circles) cells from
no less than three different animals.
Berra-Romani et al. BMC Surgery 2013, 13(Suppl 2):S40
http://www.biomedcentral.com/1471-2482/13/S2/S40
Page 11 of 17
of endothelial ablation observed after coronary stenting
in humans in patients [60], albeit it is in the same range
as that described in previous studies addressing the role
of Ca2+ signals in the regeneration of wounded mono-
layers [2,12]. However, a focal region devoid of the EC
covering is rapidly repaired by neighbouring ECs, which
spread into the lesioned area and undergo mitosis [61].
Accordingly, the daily rate of EC replication is increased
by 50% at these sites in the rat aorta [62]. Therefore, the
approach we utilized to perform the endothelial injury is
useful to: 1) get insights into the acute response to the
arterial damage in terms of Ca2+ response and accompa-
nying NO synthesis and 2) elucidate the molecular
machinery driving the subsequent process of endothelial
regeneration Three pieces of evidences suggest that
injury-induced NO synthesis is mainly driven by Ca2+
influx. First, there is no detectable NOP when the
endothelium is scraped in absence of extracellular Ca2+.
Second, injury-elicited NOP is not significantly affected
by depletion of the InsP3-sensitive Ca
2+ stores with thap-
sigargin, although we cannot rule out the possibility that
InsP3-sensitive NOP falls below the resolution of our
fluorimetric system. Third, blockade of Ca2+ entry by
classic gap junction blockers, but not by BTP-2, dampen
NO synthesis. These observations are consistent with the
Fura-2 data and strongly suggest that CxHcs, rather than
SOCE, provide the Ca2+ source driving NO liberation in
damaged endothelium. Rat aortic endothelium has been
found to express three main Cx isoforms, namely Cx37,
Cx40, and Cx43 [32,49]. In order to elucidate which of
them underpins NO synthesis, we exploited the reported
selectivity of Cx-mimetic peptides [33,45]. Both 37,43Gap27
and 40Gap27 significantly attenuated NOP triggered by
Ca2+ entry at the lesion site. The following lines of evi-
dence confirm the specificity of 37,43Gap27 and 40Gap27:
1) pre-treatment with scrambled peptides did not detecta-
bly alter injury-induced NO synthesis (present study); and
2) 37,43Gap27 and 40Gap27 do not alter endogenous
expression of Cx40 and Cx43 in the smooth muscle cell
line A7r5, as well as connexin trafficking and de novo for-
mation of gap plaques in A7r5 cells expressing Cx43-GFP
[49]. These data strongly suggest that injury-elicited NOP
at the wound edge of the aortic surface is sustained by Ca2
+ influx through Cx37Hcs, Cx40Hcs, and Cx43Hcs. These
results are further supported by previous studies, which
showed that Cx43-containing gap junctions mediate the
spreading of pro-inflammatory Ca2+ waves in lung capil-
laries [36] and sustain ATP-promoted Ca2+ bursts in uter-
ine artery ECs [63]. Consistent with the role served by
CxHc as Ca2+ entry pathways in vascular endothelium,
Cx37Hc and Cx43Hc were recently shown to maintain
bradykinin-induced intracellular Ca2+ oscillations in rat
brain endothelial cells [29], while Cx32Hc- and Cx43Hc-
mediated Ca2+ inflow supports the spiking response to
Figure 8 Effect of caveolar impairment on injury-induced signalling in the luminal face of rat aorta. Pre-treatment with 10 mM MbCD to
disrupt caveolae does not significantly affect the Ca2+ response to endothelial damage (A), but fully abolishes the accompanying NOP (C). B,
MbCD effect on both the peak and the plateau of the Ca2+ elevation. The traces are the mean±SE, respectively, of 5 (PSS, closed circles) and 4
(MbCD, open circles) cells from two aortic rings harvested from the same animal on the same day. D, MbCD effect on NOP amplitude measured
at 20 min after the injury. For both B and D, the number of ECs analyzed in each condition is indicated above the bars.
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bradykinin in Madin-Darby canine kidney cells [30]. Simi-
larly, Cx43Hcs has already been shown to mediate Ca2+
influx and activate Ca2+-dependent downstream targets in
a variety of cell types other than endothelial cells [31,64].
Caveolar integrity is required to support injury-dependent
NO synthesis in rat aortic endothelium
The subcellular analysis of the Ca2+ signal driving eNOS
activation has shown that Ca2+ entry results in a highly
localized Ca2+ microdomain which is restricted to the
inner leaflet of the plasma membrane [57,58]. Therefore,
CxHcs and eNOS are likely to tightly interact in order
for Ca2+ inflow to stimulate NOP in injured endothe-
lium. This hypothesis is supported by a number of
recent studies. First, eNOS physically interacts with both
Cx37 and Cx40 in in situ ECs of mouse aorta [65]. Sec-
ond, Cx43 colocalizes with eNOS in native ECs covering
the lumen of mice thoracodorsal arteries [66]. Third,
Cx37 coimmunoprecipitates with eNOS in a number of
human primary ECs [67]. The physical coupling between
CxHcs and eNOS might be provided by cholesterol
enriched membrane domains, such as caveolae. Indeed,
MbCD abrogated injury-triggered NOP without affecting
the underpinning Ca2+ signal. This feature suggests that
disruption of caveolae does not modify CxHs gating, but
physically displaces eNOS from the local source of Ca2+
responsible for its engagement. Consistently, caveolin-1
regulates the correct trafficking and localization to the
plasma membrane of several Cx isoforms, including Cx
37, 40, and 43 [66,68,69]. Moreover, the expression of
Cx37, Cx40 and Cx43 is decreased in caveolin-1 knock
out arteries as compared to wild-type mice [70]. On the
other hand, eNOS is targeted to caveolae by cotransla-
tional N-myristoylation and posttranslational palmitoyla-
tion and interacts with the scaffolding domain of
caveolin-1 [23]. It this, therefore, likely that caveolae
maintain CxHcs in close proximity to eNOS and, per-
haps, to other relevant signalling proteins, as recently
suggested in [70]. Interestingly, while ineffective in regu-
lating the Ca2+-mobilizing properties of CxHcs, caveolar
integrity is key to SOCE recruitment in vascular ECs
[57]. In line with these evidences, cholesterol depletion
with MbCD prevents store-operated Ca2+ inflow and
NOP triggered by ATP in native rat aortic endothelium.
The putative role of NO in lesioned endothelium
The increase in NO levels at the wound edge represents
an immediate, localized self-protecting response of the
vessel wall to EC loss. Indeed, the NO signal is confined
within the area experiencing the elevation in [Ca2+]i
induced by the injury and does not spread farther away
(see Figure 2C). EC detachment due to physiological
turnover or pathological events causes the exposition of
patches of sub-endothelial matrix which may activate
platelets, a process known to promote an inflammatory
reaction which favours the onset of atherosclerosis [71].
However, increased local NO synthesis inhibits both pla-
telet aggregation and VSMC proliferation and migration,
thus adversing both neointima formation and inflamma-
tion [1,19]. NO might play a key role also in subsequent
healing [19,59]. Accordingly, NO inhibits apoptosis and
stimulates proliferation and migration, which are an
essential pre-requisite for ECs to spread and cover the
de-endothelized area [19,59]. In injured rat aortic rings,
both eNOS protein and enzyme activity have been
shown to augment at the proliferating wound edge, but
not in ECs distant from the lesion [25]. Moreover, aortic
segments obtained from eNOS knock-out (KO) mice
and cultured in Matrigel displayed a dramatic reduction
in EC sprouting and proliferation as compared to wild-
type animals [72]. Consistent with these in vitro obser-
vations, intravenous infusion of a NO donor accelerated
in vivo regeneration of the endothelium lining the
lumen of injured rat carotid artery [73]. In addition,
neo-vascularization of ischemic hindlimbs, which
depends on EC proliferation and migration, is signifi-
cantly reduced in eNOS KO mice [74] and enhanced in
eNOS overexpressing mice [75]. Finally, NO liberated by
cells at the wound edge might recruit circulating
endothelial progenitor cells and speed up the healing
process [76].
The changes in DAF-FM fluorescence measured from
the endothelial layer could also reflect some NOP
occurring within the underlying SMCs, which generate a
Ca2+ wave in response to mechanical injury [48]. This
Ca2+ signal might, in turn, activate SMC eNOS and con-
tribute to the increase in DAF-FM fluorescence we
recorded from ECs at the wound edge [77]. However,
injury-induced Ca2+ waves in SMCs entirely depend on
intracellular Ca2+ release, rather than Ca2+ influx [48].
As a consequence, the fact that all the protocols impair-
ing injury-elicited Ca2+ inflow into ECs nearby the
lesion site (i.e. removal of external Ca2+ and exposition
to gap junction blockers) affected the accompanying
increase in DAF-FM fluorescence strongly hint at the
endothelial origin of the NO signal. Nevertheless, the
possibility that NO synthesis also takes place within the
tunica media of damaged rat aortic rings cannot be
ruled out.
Evidence for the expression of additional Cx isoforms in the
endothelium of rat aorta
The results presented in the current investigation sup-
port a role for Cx37Hcs, Cx40Hcs, and Cx43Hcs in
driving the Ca2+-dependent eNOS activation at the
wound edge of rat aortic endothelium. However, the
decay phase of the Ca2+ response to injury is not signifi-
cantly affected by 1 hour pre-treatment with Cx-
mimetic peptides. This feature concurs with the highly
localized, sub-membranal nature of the Ca2+ signal
engaging eNOS in vascular ECs [57,58], which are
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detected by genetically-encoded Ca2+ fluorophores selec-
tively targeting the caveolae, but not the bulk cytoplasm
[58]. This finding raises us to wonder about the molecu-
lar nature of the membrane pathway(s) responsible for
the massive Ca2+ influx observed during the decay
phase. As widely discussed elsewhere [2,12], the phar-
macological profile of such a route is typical of a CxHc.
The lack of effect of Cx-mimetic peptides on the bulk
increase in [Ca2+]i that features the decay phase of the
Ca2+ response to injury, therefore, suggests that Cx iso-
forms other than Cx 37, 40, and 43 are expressed in the
native endothelium of rat aorta. This hypothesis is
strongly supported by the recent discovery of Cx32
mRNA and protein in both cultured and blood vessel
ECs [50]. Cx32Hcs, in particular, has recently been
shown to mediate Ca2+ influx when transfected in HeLa
cells [78] and in Madin-Darby canine kidney cells [30].
Additional Cx isoforms that have been implicated in
Ca2+ entry across the plasmalemma are Cx26 [79] and
Cx45 [80]. That Cx isoforms other than Cx37, Cx40,
and Cx43 are expressed in the vessel wall has also been
proposed by Tang and Vanhoutte [52] and by Sorensen
et al. [81]. Both groups reached the same conclusion
upon the finding that connexin mimetic peptides failed
to reproduce the effects of classic gap junction blockers
in the vasculature. Recent evidence hinted at pannexins
(Pxs), which are hexameric channels structurally unre-
lated to Cxs, as the molecular substrates for the hemi-
channels (the so-called pannexons) present in the non-
junctional area of cell membrane [82]. However, to the
best of our knowledge, Px expression has hitherto been
reported only in microvascular beds rather than in
macrovessels, such as aorta [82]. Moreover, as recently
pointed out [2,12], Px hemichannels are unaffected by
La3+ and heptanol, which block CxHcs and impair
injury-induced Ca2+ entry in the intact endothelium of
rat aorta [26,27]. Accordingly, our preliminary data indi-
cate that probenecid, a widely employed Px blocker,
does not significantly affect the Ca2+ response to
mechanical injury in rat aortic endothelium. It is worth
of noting that Cx-mimetic peptides, either separately or
in combination, caused an increase in the InsP3-depen-
dent initial Ca2+ peak. A recent study reported that
CxHcs may mediate InsP3 efflux into the extracellular
space [83]. It is, therefore, conceivable that the pro-
longed pre-treatment with Cx-mimetic peptides pre-
vented InsP3 produced at the wound edge from moving
out of the cytosol, thus increasing the extent of Ca2+
release in the first raw of cells.
Conclusion
In conclusion, this study provides the first clear-cut evi-
dence that arterial damage activates surviving ECs to
produce NO by inducing Ca2+ entry via Cx37Hcs,
Cx40Hcs, and Cx43Hcs. Our data indicate that the
membranal compartmentalization of CxHcs and eNOS
depends on is enabled by caveolae. Experiments are
under way in our laboratory to assess the role played by
CxHcs-induced NO synthesis in the regeneration of rat
aortic endothelium. These results outline the impor-
tance of designing novel prosthetic devices able to
release NO after vascular interventions, such as arterial
bypass grafting and intravascular stent deployment [84].
Indeed, the currently employed drug-eluting stents may
result in late arterial occlusion and, eventually, in patient
death due to their reported capability to inhibit
endothelial regeneration [11]. Alternatively, the signal-
ling cascade leading to NO production that we have
described in the present work might be the alternative
target of novel drug-eluting stents. The cardiological
practice has unveiled a variety of compounds, such as
ZP123 or rotigaptide and (2S,4R)-1-(2-aminoacetyl)-4-
benzamidopyrrolidine-2-carboxylic acid hydrochloride
(GAP-134), which increase CxHc conductance and,
therefore, might be exploited to increase Ca2+ influx at
the lesion site [2,12]. These substances have successfully
been probed as orally-active and anti-arrhythmic drugs
in Phase I and II clinical trials conducted on patients
suffering either from atrial fibrillation or from unstable
angina or myocardial infarction [85,86]. In perspective,
these molecules might be locally released by drug-elut-
ing stents to improve CxHc-mediated signalling and
boost NO synthesis after surgical interventions on dis-
eased vessels [2,12].
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